I agree that this site is using cookies. You can find further informations here.
X
Lothgren, Mickael
50  results:
Search for persons X
?
1

Real-World Outcomes in Patients with Advanced/Metastatic Re..:

Heng, Daniel Y.C. ; Doshi, Gurjyot K. ; Dutailly, Pascale...
Kidney Cancer.  8 (2024)  1 - p. 99-114 , 2024
Link: https://doi.org/10.3233/..
 
?
2

Proposal for a General Outcome-based Value Attribution Fram..:

Steuten, Lotte ; Lothgren, Mickael ; Bruce, Andrew..
Value in Health.  , 2024
Link: https://doi.org/10.1016/..
 
?
3

Why We Need a New Outcomes-Based Value Attribution Framewor..:

Towse, Adrian ; Lothgren, Mickael ; Steuten, Lotte.
Value in Health.  25 (2022)  11 - p. 1821-1827 , 2022
Link: https://doi.org/10.1016/..
 
?
4

PP259 Invisible Resilience: The Value Of Medical Technology..:

Steuten, Lotte ; Zamora, Bernarda ; Lothgren, Mickael..
International Journal of Technology Assessment in Health Care.  37 (2021)  S1 - p. 31-31 , 2021
Link: https://doi.org/10.1017/..
 
?
5

Cost-effectiveness of Evolocumab in Patients With High Card..:

Villa, Guillermo ; Lothgren, Mickael ; Kutikova, Lucie...
Clinical Therapeutics.  39 (2017)  4 - p. 771-786.e3 , 2017
Link: https://doi.org/10.1016/..
 
?
6

Predicted impact of lipid lowering therapy on cardiovascula..:

Journath, Gunilla ; Hambraeus, Kristina ; Hagström, Emil..
BMC Cardiovascular Disorders.  17 (2017)  1 - p. , 2017
Link: https://doi.org/10.1186/..
 
?
7

Cost‐Effectiveness ofLDL‐C Lowering With Evolocumab in Pati..:

Gandra, Shravanthi R. ; Villa, Guillermo ; Fonarow, Gregg C....
Clinical Cardiology.  39 (2016)  6 - p. 313-320 , 2016
Link: https://doi.org/10.1002/..
 
?
8

Acute and chronic impact of cardiovascular events on health..:

Matza, Louis S ; Stewart, Katie D ; Gandra, Shravanthi R...
BMC Health Services Research.  15 (2015)  1 - p. , 2015
Link: https://doi.org/10.1186/..
 
?
9

Cost-utility of denosumab for the treatment of postmenopaus..:

Darba, Josep ; Kaskens, Lisette ; Sorio, Francesc.
ClinicoEconomics and Outcomes Research.  , 2015
Link: https://doi.org/10.2147/..
 
?
10

Hospitalisation Utilisation and Costs in Schizophrenia Pati..:

Asseburg, Christian ; Willis, Michael ; Löthgren, Mickael...
Schizophrenia Research and Treatment.  2012 (2012)  - p. 1-9 , 2012
Link: https://doi.org/10.1155/..
 
?
11

Medical Resource Utilization and Cost of HIV-Related Care i..:

Ghatnekar, Ola ; Hjortsberg, Catharina ; Gisslén, Magnus..
PharmacoEconomics.  28 (2010)  S1 - p. 49-57 , 2010
Link: https://doi.org/10.2165/..
 
?
12

Cost Effectiveness of Long-Acting Risperidone in Sweden:

Hensen, Marja ; Heeg, Bart ; Löthgren, Mickael.
Applied Health Economics and Health Policy.  8 (2010)  5 - p. 327-341 , 2010
Link: https://doi.org/10.2165/..
 
?
13

The impact on schizophrenia-related hospital utilization an..:

Willis, Michael ; Svensson, Marianne ; Löthgren, Mickael...
The European Journal of Health Economics.  11 (2010)  6 - p. 585-594 , 2010
Link: https://www.jstor.org/st..
 
?
14

Cost Effectiveness of Darunavir/Ritonavir 600/100mg bid in ..:

Moeremans, Karen ; Annemans, Lieven ; Löthgren, Mickael...
PharmacoEconomics.  28 (2010)  S1 - p. 107-128 , 2010
Link: https://doi.org/10.2165/..
 
?
15

Predicting Direct Costs of HIV Care During the First Year o..:

Hill, Andrew M. ; Gebo, Kelly ; Hemmett, Lindsay...
PharmacoEconomics.  28 (2010)  S1 - p. 169-181 , 2010
Link: https://doi.org/10.2165/..
 
1-15